<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03572725</url>
  </required_header>
  <id_info>
    <org_study_id>2018/785</org_study_id>
    <nct_id>NCT03572725</nct_id>
  </id_info>
  <brief_title>Air Tamponade and Non-supine Positioning in Macular Hole Surgery.</brief_title>
  <official_title>Air Tamponade and Non-supine Positioning in Macular Hole Surgery. A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helse Stavanger HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Trondheim University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helse Stavanger HF</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicenter, randomized non-inferiority trial, where the macular hole&#xD;
      closure rate with intraocular air tamponade is compared to the closure rate with gas&#xD;
      tamponade.The patients are randomized to receive either air or gas (26% SF6) as intraocular&#xD;
      tamponade, just prior to the intraocular flushing of the tamponade during the vitrectomy&#xD;
      procedure. Postoperatively, the patients adhere to the nonsupine regimen for three days, and&#xD;
      the tennis ball technique is used during sleep to enhance patients' positioning compliance.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 26, 2018</start_date>
  <completion_date type="Actual">May 28, 2021</completion_date>
  <primary_completion_date type="Actual">May 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Macular hole closure verified on OCT</measure>
    <time_frame>2 - 8 weeks postoperatively</time_frame>
    <description>Macular hole closure verified on OCT after one macular hole intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Closure of macular holes ≤ 250 µm</measure>
    <time_frame>2 - 8 weeks postoperatively</time_frame>
    <description>Macular hole closure verified on OCT after one macular hole intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Closure of macular holes &gt;250 µm and ≤ 400 µm</measure>
    <time_frame>2 - 8 weeks postoperatively</time_frame>
    <description>Macular hole closure verified on OCT after one macular hole intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>First postoperative day</time_frame>
    <description>Standard procedure for assessment of intraocular pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>2 - 8 weeks postoperatively</time_frame>
    <description>Standard procedure for assessment of visual acuity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Macular Holes</condition>
  <arm_group>
    <arm_group_label>Gas tamponade</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gas as intraocular tamponade.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air tamponade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Air as intraocular tamponade.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gas tamponade</intervention_name>
    <description>Removal of intraocular fluid and replacement with intraocular tamponade. No restriction of postoperative positioning with exception to the supine position. A tennis ball is attached to the back of patients at night. This measure will assists them in avoiding the nocturnal supine position.</description>
    <arm_group_label>Gas tamponade</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Air tamponade</intervention_name>
    <description>Removal of intraocular fluid and replacement with intraocular tamponade. No restriction of postoperative positioning with exception to the supine position. A tennis ball is attached to the back of patients at night. This measure will assists them in avoiding the nocturnal supine position.</description>
    <arm_group_label>Air tamponade</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary macular hole ≤ 400 μm&#xD;
&#xD;
          -  Duration no more than 24 months&#xD;
&#xD;
          -  Able to sign informed content&#xD;
&#xD;
          -  Signed informed content&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Earlier vitreoretinal surgery in present eye&#xD;
&#xD;
          -  Secondary macular holes caused by other conditions than vitreomacular traction&#xD;
&#xD;
          -  Myopic macular hole, i.e. excessive myopia (more than -6 dioptres)&#xD;
&#xD;
          -  Posttraumatic macular hole&#xD;
&#xD;
          -  Macular holes secondary to retinal detachment or other retinal diseases&#xD;
&#xD;
          -  Surgery under general anesthesia&#xD;
&#xD;
          -  Visual acuity below 20/40 in fellow-eye&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vegard Forsaa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helse Stavanger HF</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stavanger University Hospital, Department of Ophthalmology</name>
      <address>
        <city>Stavanger</city>
        <zip>4016</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of North Norway</name>
      <address>
        <city>Tromsø</city>
        <zip>9038</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trondheim University Hospital</name>
      <address>
        <city>Trondheim</city>
        <zip>7030</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>June 11, 2018</study_first_submitted>
  <study_first_submitted_qc>June 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2018</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

